Meunier A, Hernandez-Castro J, Chahley N, Communal L, Kheireddine S, Koushki N
Commun Med (Lond). 2025; 5(1):33.
PMID: 39900650
PMC: 11790846.
DOI: 10.1038/s43856-024-00702-9.
Hoshino H, Akama T, Inoue D, Moritani S, Shigeto S, Matsuda K
Hum Cell. 2025; 38(2):47.
PMID: 39878900
PMC: 11779770.
DOI: 10.1007/s13577-025-01176-0.
Geoffroy K, Viens M, Kalin E, Boudhraa Z, Roy D, Wu J
Pharmaceuticals (Basel). 2025; 17(12.
PMID: 39770503
PMC: 11677601.
DOI: 10.3390/ph17121662.
Skorupa A, Klimek M, Ciszek M, Pakulo S, Cichon T, Cichon B
Int J Mol Sci. 2024; 25(20).
PMID: 39456684
PMC: 11507550.
DOI: 10.3390/ijms252010903.
Adams K, Wendt J, Wood J, Olson S, Moreno R, Jin Z
bioRxiv. 2024; .
PMID: 39131380
PMC: 11312449.
DOI: 10.1101/2024.07.26.605381.
Oncolytic vesicular stomatitis virus alone or in combination with JAK inhibitors is effective against ovarian cancer.
Geoffroy K, Mullins-Dansereau V, Leclerc-Desaulniers K, Viens M, Bourgeois-Daigneault M
Mol Ther Oncol. 2024; 32(3):200826.
PMID: 39006945
PMC: 11246050.
DOI: 10.1016/j.omton.2024.200826.
Sialyl-Tn serves as a potential therapeutic target for ovarian cancer.
Al-Alem L, Prendergast J, Clark J, Zarrella B, Zarrella D, Hill S
J Ovarian Res. 2024; 17(1):71.
PMID: 38566237
PMC: 10985924.
DOI: 10.1186/s13048-024-01397-1.
Spheroid architecture strongly enhances miR-221/222 expression and promotes oxidative phosphorylation in an ovarian cancer cell line through a mechanism that includes restriction of miR-9 expression.
Ward A, Hall C, Tree M, Kohtz D
Mol Biol Rep. 2024; 51(1):275.
PMID: 38310615
DOI: 10.1007/s11033-023-09168-9.
Methylene Blue Metabolic Therapy Restrains In Vivo Ovarian Tumor Growth.
da Veiga Moreira J, Nleme N, Schwartz L, Leclerc-Desaulniers K, Carmona E, Mes-Masson A
Cancers (Basel). 2024; 16(2).
PMID: 38254843
PMC: 10814748.
DOI: 10.3390/cancers16020355.
Cancer cell seeding density as a mechanism of chemotherapy resistance: a novel cancer cell density index based on IC50-Seeding Density Slope (ISDS) to assess chemosensitivity.
Punyamurtula U, Brown T, Zhang S, George A, El-Deiry W
Am J Cancer Res. 2024; 13(12):5914-5933.
PMID: 38187067
PMC: 10767358.
Transcriptomic analyses of ovarian clear-cell carcinoma with concurrent endometriosis.
Collins K, Wang X, Klymenko Y, Davis N, Martinez M, Zhang C
Front Endocrinol (Lausanne). 2023; 14:1162786.
PMID: 37621654
PMC: 10445169.
DOI: 10.3389/fendo.2023.1162786.
Exploring the Control of PARP1 Levels in High-Grade Serous Ovarian Cancer.
Raspaglio G, Buttarelli M, Cappoli N, Ciucci A, Fagotti A, Scambia G
Cancers (Basel). 2023; 15(8).
PMID: 37190289
PMC: 10137242.
DOI: 10.3390/cancers15082361.
The Application of an Extracellular Vesicle-Based Biosensor in Early Diagnosis and Prediction of Chemoresponsiveness in Ovarian Cancer.
Asare-Werehene M, Hunter R, Gerber E, Reunov A, Brine I, Chang C
Cancers (Basel). 2023; 15(9).
PMID: 37174032
PMC: 10177169.
DOI: 10.3390/cancers15092566.
Hypoxia, but Not Normoxia, Reduces Effects of Resveratrol on Cisplatin Treatment in A2780 Ovarian Cancer Cells: A Challenge for Resveratrol Use in Anticancer Adjuvant Cisplatin Therapy.
Synowiec A, Brodaczewska K, Wcislo G, Majewska A, Borkowska A, Filipiak-Duliban A
Int J Mol Sci. 2023; 24(6).
PMID: 36982788
PMC: 10051682.
DOI: 10.3390/ijms24065715.
A genome-wide screen identifies SCAI as a modulator of the UV-induced replicative stress response.
Lemay J, St-Hilaire E, Ronato D, Gao Y, Belanger F, Gezzar-Dandashi S
PLoS Biol. 2022; 20(10):e3001543.
PMID: 36215310
PMC: 9584372.
DOI: 10.1371/journal.pbio.3001543.
Three-Dimensional Modelling of Ovarian Cancer: From Cell Lines to Organoids for Discovery and Personalized Medicine.
Yee C, Dickson K, Muntasir M, Ma Y, Marsh D
Front Bioeng Biotechnol. 2022; 10:836984.
PMID: 35223797
PMC: 8866972.
DOI: 10.3389/fbioe.2022.836984.
Plasma Gelsolin Confers Chemoresistance in Ovarian Cancer by Resetting the Relative Abundance and Function of Macrophage Subtypes.
Asare-Werehene M, Tsuyoshi H, Zhang H, Salehi R, Chang C, Carmona E
Cancers (Basel). 2022; 14(4).
PMID: 35205790
PMC: 8870487.
DOI: 10.3390/cancers14041039.
Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patients.
Buttarelli M, Ciucci A, Palluzzi F, Raspaglio G, Marchetti C, Perrone E
J Exp Clin Cancer Res. 2022; 41(1):50.
PMID: 35120576
PMC: 8815250.
DOI: 10.1186/s13046-022-02265-w.
Somatic Hypomethylation of Pericentromeric SST1 Repeats and Tetraploidization in Human Colorectal Cancer Cells.
Gonzalez B, Navarro-Jimenez M, Alonso-De Gennaro M, Jansen S, Granada I, Perucho M
Cancers (Basel). 2021; 13(21).
PMID: 34771515
PMC: 8582499.
DOI: 10.3390/cancers13215353.
Carboplatin response in preclinical models for ovarian cancer: comparison of 2D monolayers, spheroids, ex vivo tumors and in vivo models.
Brodeur M, Simeone K, Leclerc-Deslauniers K, Fleury H, Carmona E, Provencher D
Sci Rep. 2021; 11(1):18183.
PMID: 34521878
PMC: 8440566.
DOI: 10.1038/s41598-021-97434-w.